Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
55
MRC Quote, Financials, Valuation and Earnings
Last price:
$12.45
Seasonality move
:
2.28%
Day range:
$12.13 - $12.87
52-week range:
$9.77 - $14.91
Dividend yield:
0%
P/E ratio:
14.43x
P/S ratio:
0.34x
P/B ratio:
1.92x
Volume:
1.2M
Avg. volume:
515.4K
1-year change:
16.31%
Market cap:
$1.1B
Revenue:
$3.4B
EPS (TTM):
$0.87
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $2.6B | $2.7B | $3.4B | $3.4B | |
| Revenue Growth (YoY) | -12.22% | -30.09% | 4.14% | 26.14% | 1.46% | |
| Cost of Revenues | $3B | $2.1B | $2.2B | $2.8B | $2.7B | |
| Gross Profit | $653M | $431M | $417M | $610M | $690M | |
| Gross Profit Margin | 17.83% | 16.84% | 15.64% | 18.14% | 20.22% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $550M | $449M | $410M | $470M | $503M | |
| Other Inc / (Exp) | $3M | -$237M | $2M | -$6M | -$2M | |
| Operating Expenses | $550M | $449M | $410M | $470M | $503M | |
| Operating Income | $103M | -$18M | $7M | $140M | $187M | |
| Net Interest Expenses | $40M | $28M | $23M | $24M | $32M | |
| EBT. Incl. Unusual Items | $66M | -$283M | -$14M | $110M | $153M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27M | -$9M | -- | $35M | $39M | |
| Net Income to Company | $39M | -$274M | -$14M | $75M | $114M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $39M | -$274M | -$14M | $75M | $114M | |
| Basic EPS (Cont. Ops) | $0.18 | -$3.63 | -$0.46 | $0.61 | $1.07 | |
| Diluted EPS (Cont. Ops) | $0.18 | -$3.63 | -$0.46 | $0.60 | $1.05 | |
| Weighted Average Basic Share | $83M | $82M | $82.5M | $83.5M | $84.2M | |
| Weighted Average Diluted Share | $83.9M | $82M | $82.5M | $84.9M | $85.5M | |
| EBITDA | $169M | -$209M | $52M | $173M | $225M | |
| EBIT | $106M | -$255M | $9M | $134M | $185M | |
| Revenue (Reported) | $3.7B | $2.6B | $2.7B | $3.4B | $3.4B | |
| Operating Income (Reported) | $103M | -$18M | $7M | $140M | $187M | |
| Operating Income (Adjusted) | $106M | -$255M | $9M | $134M | $185M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $585M | $685M | $904M | $888M | $797M | |
| Revenue Growth (YoY) | -37.9% | 17.09% | 31.97% | -1.77% | -10.25% | |
| Cost of Revenues | $471M | $590M | $739M | $705M | $637M | |
| Gross Profit | $114M | $95M | $165M | $183M | $160M | |
| Gross Profit Margin | 19.49% | 13.87% | 18.25% | 20.61% | 20.08% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $100M | $102M | $120M | $126M | $123M | |
| Other Inc / (Exp) | $1M | -- | -$5M | $1M | -$1M | |
| Operating Expenses | $100M | $102M | $120M | $126M | $123M | |
| Operating Income | $14M | -$7M | $45M | $57M | $37M | |
| Net Interest Expenses | $7M | $6M | $6M | $9M | $4M | |
| EBT. Incl. Unusual Items | $8M | -$13M | $34M | $49M | $32M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5M | -$2M | $10M | $14M | $3M | |
| Net Income to Company | $3M | -$11M | $24M | $35M | $29M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3M | -$11M | $24M | $35M | $29M | |
| Basic EPS (Cont. Ops) | -$0.04 | -$0.21 | $0.22 | $0.34 | $0.27 | |
| Diluted EPS (Cont. Ops) | -$0.04 | -$0.21 | $0.21 | $0.33 | $0.27 | |
| Weighted Average Basic Share | $82.1M | $82.7M | $83.6M | $84.3M | $85.2M | |
| Weighted Average Diluted Share | $82.1M | $82.7M | $85M | $105.9M | $86.2M | |
| EBITDA | $27M | $3M | $49M | $68M | $47M | |
| EBIT | $15M | -$7M | $40M | $58M | $36M | |
| Revenue (Reported) | $585M | $685M | $904M | $888M | $797M | |
| Operating Income (Reported) | $14M | -$7M | $45M | $57M | $37M | |
| Operating Income (Adjusted) | $15M | -$7M | $40M | $58M | $36M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.6B | $3.2B | $3.5B | $3.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.3B | $2.2B | $2.6B | $2.8B | $2.6B | |
| Gross Profit | $472M | $400M | $559M | $695M | $649M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $493M | $401M | $453M | $501M | $499M | |
| Other Inc / (Exp) | -$243M | $7M | -$10M | $2M | -$1M | |
| Operating Expenses | $493M | $401M | $453M | $501M | $499M | |
| Operating Income | -$21M | -$1M | $106M | $194M | $150M | |
| Net Interest Expenses | $31M | $24M | $22M | $33M | $25M | |
| EBT. Incl. Unusual Items | -$295M | -$18M | $74M | $163M | $124M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2M | -$3M | $24M | $49M | $25M | |
| Net Income to Company | -$293M | -$15M | $50M | $114M | $99M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$293M | -$15M | $50M | $114M | $99M | |
| Basic EPS (Cont. Ops) | -$3.87 | -$0.47 | $0.32 | $1.06 | $0.88 | |
| Diluted EPS (Cont. Ops) | -$3.87 | -$0.47 | $0.30 | $1.05 | $0.87 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$215M | $49M | $136M | $236M | $190M | |
| EBIT | -$264M | $6M | $96M | $196M | $149M | |
| Revenue (Reported) | $2.7B | $2.6B | $3.2B | $3.5B | $3.2B | |
| Operating Income (Reported) | -$21M | -$1M | $106M | $194M | $150M | |
| Operating Income (Adjusted) | -$264M | $6M | $96M | $196M | $149M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | $2B | $2.5B | $2.6B | $2.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.6B | $1.7B | $2B | $2.1B | $1.9B | |
| Gross Profit | $341M | $310M | $452M | $537M | $496M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $352M | $304M | $347M | $378M | $374M | |
| Other Inc / (Exp) | -$243M | $1M | -$11M | -$3M | -$2M | |
| Operating Expenses | $352M | $304M | $347M | $378M | $374M | |
| Operating Income | -$11M | $6M | $105M | $159M | $122M | |
| Net Interest Expenses | $22M | $18M | $17M | $26M | $19M | |
| EBT. Incl. Unusual Items | -$276M | -$11M | $77M | $130M | $101M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$7M | -$1M | $23M | $37M | $23M | |
| Net Income to Company | -$269M | -$10M | $54M | $93M | $78M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$269M | -$10M | $54M | $93M | $78M | |
| Basic EPS (Cont. Ops) | -$3.50 | -$0.34 | $0.44 | $0.88 | $0.70 | |
| Diluted EPS (Cont. Ops) | -$3.50 | -$0.34 | $0.42 | $0.87 | $0.70 | |
| Weighted Average Basic Share | $245.8M | $247.6M | $250.5M | $252.6M | $255.1M | |
| Weighted Average Diluted Share | $246.5M | $247.6M | $254.2M | $276.6M | $258.7M | |
| EBITDA | -$219M | $39M | $123M | $186M | $151M | |
| EBIT | -$254M | $7M | $94M | $156M | $120M | |
| Revenue (Reported) | $2B | $2B | $2.5B | $2.6B | $2.4B | |
| Operating Income (Reported) | -$11M | $6M | $105M | $159M | $122M | |
| Operating Income (Adjusted) | -$254M | $7M | $94M | $156M | $120M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $32M | $119M | $48M | $32M | $131M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $459M | $319M | $379M | $501M | $430M | |
| Inventory | $701M | $509M | $453M | $578M | $560M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $26M | $19M | $19M | $31M | $34M | |
| Total Current Assets | $1.2B | $966M | $899M | $1.1B | $1.2B | |
| Property Plant And Equipment | $324M | $303M | $282M | $284M | $283M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $483M | $264M | $264M | $264M | $264M | |
| Other Intangibles | $281M | $229M | $204M | $183M | $163M | |
| Other Long-Term Assets | $19M | $19M | $22M | $22M | $21M | |
| Total Assets | $2.3B | $1.8B | $1.7B | $1.9B | $1.9B | |
| Accounts Payable | $357M | $264M | $321M | $410M | $355M | |
| Accrued Expenses | $91M | $94M | $80M | $115M | $102M | |
| Current Portion Of Long-Term Debt | $4M | $4M | $2M | $3M | $292M | |
| Current Portion Of Capital Lease Obligations | $34M | $37M | $33M | $36M | $34M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $486M | $399M | $436M | $564M | $783M | |
| Long-Term Debt | $547M | $379M | $295M | $337M | $9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.1B | $993M | $1.2B | $1B | |
| Common Stock | $356M | $356M | $356M | $356M | $356M | |
| Other Common Equity Adj | -$232M | -$234M | -$231M | -$230M | -$228M | |
| Common Equity | $642M | $350M | $323M | $386M | $488M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $997M | $705M | $678M | $741M | $843M | |
| Total Liabilities and Equity | $2.3B | $1.8B | $1.7B | $1.9B | $1.9B | |
| Cash and Short Terms | $32M | $119M | $48M | $32M | $131M | |
| Total Debt | $551M | $383M | $297M | $340M | $301M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $40M | $47M | $29M | $52M | $62M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $343M | $399M | $526M | $518M | $478M | |
| Inventory | $582M | $471M | $584M | $620M | $462M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $29M | $28M | $30M | $35M | $41M | |
| Total Current Assets | $994M | $945M | $1.2B | $1.2B | $1B | |
| Property Plant And Equipment | $296M | $278M | $277M | $283M | $270M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $264M | $264M | $264M | $264M | $264M | |
| Other Intangibles | $235M | $210M | $189M | $168M | $148M | |
| Other Long-Term Assets | $16M | $22M | $23M | $18M | $31M | |
| Total Assets | $1.8B | $1.7B | $1.9B | $2B | $1.8B | |
| Accounts Payable | $293M | $329M | $479M | $438M | $382M | |
| Accrued Expenses | $86M | $76M | $96M | $111M | $108M | |
| Current Portion Of Long-Term Debt | $4M | $2M | $3M | $3M | -- | |
| Current Portion Of Capital Lease Obligations | $34M | $33M | $34M | $38M | $34M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $417M | $440M | $612M | $590M | $524M | |
| Long-Term Debt | $405M | $323M | $338M | $300M | $85M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1B | $1.2B | $1.1B | $844M | |
| Common Stock | $356M | $356M | $356M | $356M | $356M | |
| Other Common Equity Adj | -$245M | -$233M | -$234M | -$234M | -$225M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $702M | $686M | $718M | $818M | $912M | |
| Total Liabilities and Equity | $1.8B | $1.7B | $1.9B | $2B | $1.8B | |
| Cash and Short Terms | $40M | $47M | $29M | $52M | $62M | |
| Total Debt | $409M | $325M | $341M | $303M | $85M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $39M | -$274M | -$14M | $75M | $114M | |
| Depreciation & Amoritzation | $63M | $46M | $43M | $39M | $40M | |
| Stock-Based Compensation | $16M | $12M | $12M | $13M | $14M | |
| Change in Accounts Receivable | $127M | $141M | -$61M | -$128M | $72M | |
| Change in Inventories | $95M | $173M | -$27M | -$196M | $16M | |
| Cash From Operations | $242M | $261M | $56M | -$20M | $181M | |
| Capital Expenditures | $18M | $11M | $10M | $11M | $15M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$16M | $19M | -$7M | -$11M | -$14M | |
| Dividends Paid (Ex Special Dividend) | -$24M | -$24M | -$24M | -$24M | -$24M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1B | $658M | $389M | $824M | $847M | |
| Long-Term Debt Repaid | -$1.1B | -$819M | -$476M | -$781M | -$885M | |
| Repurchase of Common Stock | -$81M | -$4M | -$4M | -$2M | -$4M | |
| Other Financing Activities | -$4M | -$6M | -$3M | -- | -$1M | |
| Cash From Financing | -$238M | -$195M | -$118M | $17M | -$67M | |
| Beginning Cash (CF) | $43M | $32M | $119M | $48M | $32M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$12M | $85M | -$69M | -$14M | $100M | |
| Ending Cash (CF) | $32M | $119M | $48M | $32M | $131M | |
| Levered Free Cash Flow | $224M | $250M | $46M | -$31M | $166M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3M | -$11M | $24M | $35M | $29M | |
| Depreciation & Amoritzation | $12M | $10M | $9M | $10M | $11M | |
| Stock-Based Compensation | $3M | $3M | $3M | $3M | $4M | |
| Change in Accounts Receivable | $41M | -$19M | -$43M | -$1M | $6M | |
| Change in Inventories | $61M | -$23M | -$61M | $56M | $55M | |
| Cash From Operations | $94M | -$31M | $33M | $102M | $96M | |
| Capital Expenditures | $3M | $2M | $3M | $5M | $9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2M | -$2M | -$3M | -$7M | -$9M | |
| Dividends Paid (Ex Special Dividend) | -$6M | -$6M | -$6M | -$6M | -$6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $130M | $165M | $234M | $213M | $94M | |
| Long-Term Debt Repaid | -$195M | -$137M | -$248M | -$277M | $134M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1M | -$3M | -$1M | -$3M | -$295M | |
| Cash From Financing | -$72M | $19M | -$21M | -$73M | -$73M | |
| Beginning Cash (CF) | $19M | $63M | $21M | $31M | $49M | |
| Foreign Exchange Rate Adjustment | $1M | -$2M | -$1M | -$1M | -$1M | |
| Additions / Reductions | $20M | -$14M | $9M | $22M | $14M | |
| Ending Cash (CF) | $40M | $47M | $29M | $52M | $62M | |
| Levered Free Cash Flow | $91M | -$33M | $30M | $97M | $87M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$293M | -$15M | $50M | $114M | $99M | |
| Depreciation & Amoritzation | $49M | $43M | $40M | $40M | $41M | |
| Stock-Based Compensation | $12M | $14M | $11M | $14M | $15M | |
| Change in Accounts Receivable | $241M | -$50M | -$139M | $11M | $45M | |
| Change in Inventories | $141M | $56M | -$209M | -$44M | $159M | |
| Cash From Operations | $286M | $99M | $10M | $102M | $286M | |
| Capital Expenditures | $14M | $9M | $12M | $13M | $28M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$13M | $22M | -$13M | -$13M | -$24M | |
| Dividends Paid (Ex Special Dividend) | -$24M | -$24M | -$24M | -$24M | -$24M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $802M | $429M | $668M | $998M | $456M | |
| Long-Term Debt Repaid | -$1B | -$426M | -$737M | -$1B | -$385M | |
| Repurchase of Common Stock | -$15M | -$3M | -$4M | -$4M | -$5M | |
| Other Financing Activities | -$7M | -$91M | -- | -- | -- | |
| Cash From Financing | -$258M | -$115M | -$12M | -$65M | -$251M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $15M | $6M | -$15M | $24M | $11M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $272M | $90M | -$2M | $89M | $258M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$269M | -$10M | $54M | $93M | $78M | |
| Depreciation & Amoritzation | $35M | $32M | $29M | $30M | $31M | |
| Stock-Based Compensation | $8M | $10M | $9M | $10M | $11M | |
| Change in Accounts Receivable | $110M | -$81M | -$159M | -$20M | -$47M | |
| Change in Inventories | $102M | -$15M | -$197M | -$45M | $98M | |
| Cash From Operations | $178M | $16M | -$30M | $92M | $197M | |
| Capital Expenditures | $8M | $6M | $8M | $10M | $23M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7M | -$4M | -$10M | -$12M | -$22M | |
| Dividends Paid (Ex Special Dividend) | -$18M | -$18M | -$18M | -$18M | -$18M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $519M | $290M | $569M | $743M | $352M | |
| Long-Term Debt Repaid | -$655M | -$262M | -$523M | -$776M | -$276M | |
| Repurchase of Common Stock | -$3M | -$2M | -$2M | -$4M | -$5M | |
| Other Financing Activities | -$5M | -$90M | -$2M | -$3M | -$295M | |
| Cash From Financing | -$162M | -$82M | $24M | -$58M | -$242M | |
| Beginning Cash (CF) | $79M | $314M | $100M | $102M | $326M | |
| Foreign Exchange Rate Adjustment | -$1M | -$2M | -$3M | -$2M | -$2M | |
| Additions / Reductions | $9M | -$70M | -$16M | $22M | -$67M | |
| Ending Cash (CF) | $87M | $242M | $81M | $122M | $257M | |
| Levered Free Cash Flow | $170M | $10M | -$38M | $82M | $174M | |
Get MRC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MRC
Sector
P/E ratio
14.43x
17.94x
PEG ratio
2.22x
0.34x
P/B ratio
1.92x
1.76x
Price / LTM sales
0.34x
0.97x
Growth Metrics
MRC
Sector
Revenue growth
-10.25%
1.77%
Earnings growth
-18.18%
1.67%
Revenue (5-year growth)
-3.94%
4.31%
Earnings forecast
$0.19
$0.46
Profitability
MRC
Sector
Profitability FY 2023
$690M
$434.2M
Return on invested capital
9.1%
5.93%
Return on assets
5.32%
3.69%
Return on equity
11.51%
8.87%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Feb
4
Balance Sheet
MRC
Sector
Total cash
$62M
$170.4M
Short term investments
--
$46.5M
Total assets
$1.9B
$2.1B
Long term debt
$85M
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.14% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 5% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 2.61% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
